Raymond James & Associates’s Adverum Biotechnologies ADVM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,900	Closed	-$172K	–	3350
2017 Q4	$172K	Buy	+4,900	New	+$172K	﹤0.01%	3081